Drug Manufacturers, Technology

Modular and Digitised Pharma Production

Dividella is working with Medipak Systems sister companies to find new answers to the question of what does modularity offer in the digitisation of industrial production.

Digitisation, including the use of big data and interconnectivity, has considerable potency in generating sustainable competitive advantages for the pharmaceutical industry, particularly in embracing Industry 4.0 design philosophies.

However, to take maximum advantage of smart technologies means embracing modular approach at every level from design concepts to engineering, construction and processes. This is essential to fully exploit the connectivity and data-sharing that are inherent parts of the Industry 4.0 concept and its Pharma 4.0 derivative.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.